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442Objective: Cardiac transplantation (OHT) using diabetic donors (DDs) is thought to adversely influence
survival. We attempt to determine if adult OHT can be safely performed using selected DDs.
Methods: The United Network for Organ Sharing (UNOS) database was examined for adult OHT from 2000 to
2010.
Results: Of the 20,348 patients undergoing OHT, 496 (2.4%) were with DDs. DDs were older (39.6 vs 31.3
years; P<.001), more likely female (41.5% vs 28.3%; P<.001), and had a higher body mass index (BMI)
(29.9 vs 26.4; P< .001). Recipients of DD hearts were older (53.4 vs 51.8; P ¼ .004) and more likely to
have diabetes (18.9% vs 14.9%; P ¼ .024). The 2 groups were evenly matched with regard to recipient male
gender (78.0% vs 76.1%; P¼ .312), ischemic time (3.3 vs 3.2 hours; P¼ .191), human leukocyte antigen mis-
matches (4.7 vs 4.6; P ¼ .483), and requirement of extracorporeal membrane oxygenation (ECMO) as a bridge
to transplant (0.8% vs 0.5%; P ¼ .382). Median survival was similar (3799 vs 3798 days; P ¼ .172). On mul-
tivariate analysis, DDwas not associated with mortality (hazard ratio [HR], 1.155; 95% confidence interval [CI],
0.943-1.415; P¼ .164). As previously demonstrated, donor age, decreasing donor BMI, ischemic time, recipient
creatinine, recipient black race, recipient diabetes, race mismatch, and mechanical ventilation or ECMO as
a bridge to transplant were associated with mortality. On multivariate analysis of subgroups, neither insulin-
dependent diabetes (1.173; 95% CI, 0.884-1.444; P ¼ .268) nor duration of diabetes for more than 5 years
(HR, 1.239; 95% CI, 0.914-1.016; P ¼ .167) was associated with mortality.
Conclusions: OHT can be safely performed using selected DDs. Consensus criteria for acceptable cardiac
donors can likely be revised to include selected DDs. (J Thorac Cardiovasc Surg 2013;146:442-7)Cardiac transplantation remains the accepted treatment of
choice for end-stage heart failure.1 However, increasing
wait list mortality and donor shortages obligate us to inves-
tigate means by which the number of available donors
might be expanded. Numerous attempts to increase the do-
nor pool have been made, and this has led to the use of donor
hearts once thought to be unsuitable for transplantation.2-8
Multiple donor and recipient characteristics have been
shown to influence survival in cardiac transplantation.9-13
Existing data on the use of hearts of diabetic donors,
which otherwise fulfill standard criteria for donation, have
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The Journal of Thoracic and Cardiovascular Surgwhether adult cardiac transplantation can be safely
performed using diabetic donors who otherwise fulfill
standard criteria for organ donation according to the
United Network for Organ Sharing (UNOS) database. We
examined donor insulin dependence and duration of
diabetes to determine whether these factors affected
recipient survival. We hypothesized that cardiac
transplantation could be safely performed using diabetic
donors.
METHODS
Data Source
After approval from our local institutional review board, public-use data
files were obtained from the UNOS registry. There were 20,348 primary,
adult heart transplants performed in the United States from January 2000
to December 2010 in recipients aged 18 years or older as reported to
UNOS. Of these, 496 (2.4%) patients received a donor heart from a diabetic
donor. This cohort of patients was compared with patients receiving a heart
from nondiabetic donors. The primary end point measured was risk-
adjusted all-cause mortality. Secondary end points include acute rejection
episodes before discharge and total hospital length of stay. The presence of
donor diabetes in the UNOS database was based on medical history.
Statistical Analysis
Student t test and c2 test were used to examine continuous and categor-
ical variables. Continuous variables are presented as mean  standard de-
viation and categorical variables are reported as percentages of the total
number of data points available for that field. Survival curves wereery c August 2013
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BMI ¼ body mass index
CI ¼ confidence interval
ECMO ¼ extracorporeal membrane oxygenation
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test. Cox proportional regression analysis was performed in 2 steps. First,
covariates were run in a univariate analysis as predictors of mortality. Next,
covariates with a P value< .20 were entered simultaneously in the Cox
model. In addition, we tested 2-way interactions between donor diabetes
and recipient age, recipient gender, donor age, donor gender, ischemic
time, and recipient history of diabetes. Because none of these interactions
was significant, they were not retained in the final model. Covariates miss-
ing greater than 15% of data in the registry were excluded from the anal-
ysis. Survival was determined using all-cause mortality.RESULTS
Recipient Characteristics
Recipient characteristics are shown in Table 1. Recipi-
ents of hearts from diabetic donors were older (51.8 vs
53.4 years; P ¼ .004), more likely to have diabetes them-
selves (14.9% vs 18.9%; P¼ .024), were more likely to re-
ceive hearts from opposite sex donors (27.7% vs 32.9%;
P¼ .011), andmore likely to require mechanical ventilation
while awaiting transplantation (2.8% vs 4.8%; P ¼ .007).
The 2 groups were evenly matched with regard to gender,
ethnicity, body mass index (BMI), ischemic time, cardiac
output, pulmonary vascular resistance, race mismatch,
number of total human leukocyte antigen mismatches, pre-
transplant serum creatinine, and requirement of extracorpo-
real membrane oxygenation (ECMO) as a bridge to
transplantation.T
XDonor Characteristics
Donor characteristics are shown in Table 2. Donors with
diabetes were older (31.3 vs 39.6 years; P< .001), less
likely to be male (71.7 vs 58.5; P<.001), and had higher
BMI (26.4 vs 29.9 kg/m2; P ¼ .001). Diabetic donors
were also more likely to be evaluated with coronary angiog-
raphy (20.5% vs 48.2%;P<.001) and less likely to be eval-
uated by echocardiography (97.5% vs 94.2%; P<.001).
The 2 donor groups were evenly matched with regard to
ejection fraction, creatinine clearance, requirement of ino-
tropic support or vasodilators at procurement, requirement
of antihypertensive agents at crossclamp, and medical his-
tory of myocardial infarction. Diabetic donors were more
likely to be heavy smokers (>20 pack-year history)
(24.5% vs 28.8%; P ¼ .031), have a history of cancer
(1.7% vs 3.6%; P¼ .007), or display clinical signs of infec-
tion (37.4% vs 42.9%; P ¼ .016). There were 84 (16.9%)The Journal of Thoracic and Cadiabetic donors whose hearts were transplanted into dia-
betic recipients.
Posttransplant Outcomes
Posttransplant outcomes are shown in Table 3. When out-
comes in recipients of selected diabetic donors were com-
pared with outcomes in recipients who received organs
from nondiabetic donors, there was no difference in number
of acute rejection episodes during initial hospitalization,
length of stay, and need for retransplantation.
Mortality
Kaplan-Meier survival curves comparing recipients of
hearts from diabetic donors with the control group are
shown in Figure 1, A. There was no significant difference
in 1-year (84.2% vs 87.0%) and 3-year survival (73.1%
vs 70.1%; P¼ .172). On univariate analysis, use of diabetic
donor hearts was not associated with increased mortality
(hazard ratio [HR]; 1.126, 95% confidence interval [CI],
0.949-1.336; P¼ .172). The results of Cox proportional re-
gression analysis are shown in Table 4. On Cox proportional
regression analysis, receiving a diabetic donor heart (HR,
1.155; 95% CI, 0.943-1.415; P ¼ .164) was not indepen-
dently associated with mortality. As previously described,
variables associated with mortality included increasing
donor age (HR, 1.012 per year; 95% CI, 1.010-1.015;
P < .001), longer ischemic time (HR, 1.096 per hour;
95% CI, 1.065-1.128; P<.001), recipient creatinine (HR,
1.108/mg/dL; 95% CI, 1.082-1.134; P< .001), recipient
black race (HR, 1.343; 95% CI, 1.231-1.465; P< .001),
race mismatch (HR, 1.098; 95% CI, 1.023-1.178;
P ¼ .010), and use of mechanical ventilation (HR, 2.266;
95% CI, 1.954-2.628; P< .001), or ECMO (HR, 2.550;
95% CI, 1.854-3.506; P<.001) as a bridge to transplanta-
tion. Increasing donor BMI was associated with survival
(HR, 0.989/kg/m2; 95% CI, 0.983-0.995; P ¼ .003). In ad-
dition, there were no significant interactions between dia-
betic donor hearts and recipient age (P ¼ .986), recipient
gender (P ¼ .991), donor age (P ¼ .525), donor gender
(P ¼ .461), ischemic time (0.302), or recipient diabetes
(P ¼ .792). Median follow-up for the study group was
1189.5 days.
Of the 496 diabetic donors, 222 (44.8%) had insulin-
dependent diabetes. As shown in Figure 1, B, there was no
significant difference in survival when comparing recipients
of insulin-dependent diabetic donor hearts to non–insulin-
dependent diabetic donor hearts nor to the control group.
Of the 496 diabetic donors, 182 (36.7%) had a history of di-
abetes mellitus for over 5 years. There was no difference in
median survival when using donors with a history of diabetes
mellitus for greater than 5 years when compared with those
with diabetes mellitus for 5 years or less or with the control
group (Figure 1, C). On Cox proportional regression analysis
of these subgroups, neither insulin-dependent diabetes (HR,rdiovascular Surgery c Volume 146, Number 2 443
TABLE 1. Baseline recipient characteristics
No. available Nondiabetic donor (n ¼ 19,852) No. available Diabetic donor (n ¼ 496) P value
Age (y) 19,852 51.8  12.4 496 53.4  11.8 .004
Male gender 19,852 15,100 (76.1) 496 387 (78.0) .312
White 19,852 14,459 (72.8) 496 366 (73.8) .697
Black 19,852 3,286 (16.6) 496 89 (17.9) —
Hispanic 19,852 829 (4.2) 496 16 (3.2) —
Asian 19,852 475 (2.4) 496 8 (1.6) —
American Indian/Alaskan 19,852 64 (0.3) 496 0 (0.0) —
Hawaiian/Pacific Islander 19,852 51 (0.3) 496 1 (0.2) —
Multiracial 19,852 686 (3.5) 496 16 (3.2) —
Recipient BMI 19,176 26.9  21.9 483 27.2  5.1 .798
Recipient diabetes 2,633 (14.9) 84 (18.9) .024
Mean ischemic time (h) 18,627 3.2  1.0 469 3.3  1.1 .191
Cardiac output (L/min) 17,773 4.3  1.4 442 4.2  1.3 .255
Mean PVR (Wood units) 15,304 2.37  2.0 394 2.5  2.4 .191
Sex mismatch 19,852 5,500 (27.7) 496 163 (32.9) .011
Race mismatch 19,852 8,551 (43.1) 496 220 (44.4) .569
No. of HLA mismatches 16,880 4.6  1.1 430 4.7  1.1 .483
Creatinine before transplant (mg/dL) 19,448 1.4  0.9 486 1.4  0.7 .882
Creatinine clearance (mL/min) 19,230 82.0  38.6 480 80.8  32.3 .438
Mechanical ventilation before transplant 19,852 553 (2.8) 496 24 (4.8) .007
ECMO before transplant 19,852 103 (0.5) 496 4 (0.8) .382
BMI, Body mass index; PVR, pulmonary vascular resistance; HLA, human leukocyte antigen; ECMO, extracorporeal membrane oxygenation.
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X1.173; 95%CI, 0.884-1.444;P¼ .268) nor duration of diabe-
tes over 5 years (HR, 1.239; 95% CI, 0.914-1.016; P¼ .167)
was associated with mortality after cardiac transplantation.
We wished to test the hypothesis that outcome was supe-
rior in patients who received a heart from a diabetic donor
who had undergone coronary angiography. Therefore, sub-
group analysis was carried out on the 238 (48.2%) of dia-
betic donors that were evaluated with coronary
angiography. Cox proportional regression analysis of this
subgroup showed no association with mortality (HR,TABLE 2. Donor characteristics
No. available
N
Donor age (y) 19,852
Donor Male 19,852
Donor BMI 19,852
Donor heavy cigarette use 19,740
Ejection fraction (%) 19,151
Serum creatinine (mg/dL) 19,824
Creatinine clearance (mL/min) 19,824
Evaluation with echocardiogram 19,138
Evaluation with coronary angiography 19,658
Requirement of inotropic support at procurement 14,062
Requirement of antihypertensives before crossclamp 19,783
Requirement of vasodilator before crossclamp 19,788
History of myocardial infarction 19,784
Donor history of cancer 19,844
Donor cocaine use 19,492
Donor history of infection 18,877
BMI, Body mass index.
444 The Journal of Thoracic and Cardiovascular Surg1.191; 95%CI, 0.891-1.591; P¼ .238). Similarly, use of di-
abetic donor hearts that were not evaluated with coronary
angiography was not associated with mortality (HR,
1.129; 95% CI, 0.851-1.498; P ¼ .400).
CONCLUSIONS
Heart transplantation remains the gold standard for end-
stage heart failure.1,15,16 Increased efforts in expanding the
donor pool have led to the use of donor hearts once
thought to be unsafe for transplantation.2-8 This hasondiabetic donor
(n ¼ 19,852) No. available
Diabetic donor
(n ¼ 496) P value
31.3  12.3 496 39.6  11.5 <.001
14,226 (71.7) 496 290 (58.5) <.001
26.4  5.5 496 29.9  6.7 <.001
4,832 (24.5) 459 141 (28.8) .031
61.6  7.9 480 61.7  7.2 .655
1.2  1.1 496 1.5  1.5 <.001
120  56.1 496 114.6  61.2 .053
18,664 (97.5) 481 453 (94.2) <.001
4,028 (20.5) 494 238 (48.2) <.001
7,967 (56.7) 392 237 (60.5) .134
3,901 (19.7) 494 94 (19.0) .703
2,522 (12.8) 496 67 (13.5) .615
197 (1.0) 491 8 (1.6) .166
338 (1.7) 495 18 (3.6) .007
2,572 (13.0) 491 71 (14.3) .309
7,051 (37.4) 478 205 (42.9) .016
ery c August 2013
TABLE 3. Postoperative outcomes
No. available Nondiabetic donor (n ¼ 19,852) No. available Diabetic donor (n ¼ 496) P value
Acute rejection episode before discharge 12,139 1,821 (15.0) 358 52 (14.5) .863
Deaths 19,850 5,212 (26.3) 496 130 (26.2) .926
Retransplant 19,850 216 (1.1) 496 5 (1.0) .926
Length of stay (d) 19,620 20.1  25.0 488 21.2  21.9 .339
Taghavi et al Cardiothoracic Transplantationresulted in use of older donors17-19 and organs with longer
ischemic time.20,21 In this study, we attempt to determine
whether carefully selected hearts from donors with
diabetes could be used with acceptable outcomes. We
hypothesized that the use of carefully accepted donor
hearts from persons with diabetes is safe, even in donors
who are dependent on insulin or have had diabetes for
more than 5 years.
Existing studies on the associations between donor dia-
betes and outcomes after heart transplantation are conflict-
ing.8,14 Smits and associates14 designed and validated
a donor scoring system for heart transplantation using
the Eurotransplant Registry. In this study, donor diabetes
was not associated with increased recipient mortality.
However, this study consisted of only 41 diabetic donors,
which did not allow for meaningful subgroup analysis.
Stehlik and colleagues8 analyzed the Cardiac Transplant
Research Database, also finding no overall relationship be-
tween donor diabetes and outcomes. The authors did, how-
ever, note that in a subgroup of male donors (n ¼ 85),
worse outcomes were associated with diabetes. We were
unable to demonstrate this interaction between donor gen-
der and diabetes, as Stehlik and coworkers8 did, nor were
we able to demonstrate significant interactions between di-
abetic donors and donor age, recipient gender, recipient
age, or ischemic time. There were 84 diabetic donor hearts
that were transplanted into diabetic recipients. There was
not a significant interaction between diabetic donor hearts
and diabetic recipients, indicating that outcomes are no
different when both donor and recipient are diabetic. AsFIGURE 1. A, Kaplan-Meier survival curves comparing recipients of nondiab
Comparison of recipients of insulin-dependent (1) and non–insulin-dependent
(3). C, Comparison of recipients of donor hearts with a history of diabetes of 5 ye
donor hearts (3). IDDM, Insulin-dependent diabetes mellitus; NIDDM, non–ins
The Journal of Thoracic and Casuch, these findings from a large national database indicate
that the use of carefully selected donor hearts that fulfill
standard criteria for transplantation but also are affected
by diabetes does not appear to be associated with increased
recipient mortality. Given that these findings were consis-
tent across a wide range of subgroup analyses, it is there-
fore likely that carefully selected hearts from donors with
diabetes can be used for transplantation with acceptable
outcomes.
On subgroup analysis, neither insulin dependence nor
duration of diabetes was associated with increased mortal-
ity. A power analysis demonstrated that there were suffi-
cient numbers of insulin-dependent donors. A 2-sided
log-rank test with an overall sample size of 20,346 sub-
jects (19,850 in the control group and 496 in the experi-
mental group) achieved 91.7% power at a .05
significance level to detect a hazard ratio of 1.173 as
seen in the subjects with insulin-dependent diabetes. For
duration of diabetes, the same analysis achieved 99.0%
power at a .05 significance level to detect a hazard ratio
of 1.239 as seen in donors with duration of diabetes for
over 5 years. The UNOS database does not have informa-
tion regarding donor insulin requirement. Further studies
are needed to determine whether degree of donor insulin
dependence is associated with recipient survival. In addi-
tion, data on donor blood sugar control, severity of diabe-
tes, or presence of end-organ damage secondary to
diabetes was not available. Further research is needed to
determine how these markers may affect recipient sur-
vival. This in turn may shed additional light on how toetic donor hearts (N) with patients receiving diabetic donor hearts (Y). B,
diabetic donor hearts (2) with patients receiving nondiabetic donor hearts
ars or less (1) and more than 5 years (2)with patients receiving nondiabetic
ulin-dependent diabetes mellitus; DM, diabetes mellitus.
rdiovascular Surgery c Volume 146, Number 2 445
T
X
TABLE 4. Multiple variable model predicting risk of mortality overall
Hazard
ratio
95% Confidence
interval
P
value
Diabetic donor 1.155 0.943-1.415 .164
Donor age (per y) 1.012 1.010-1.015 <.001
Donor BMI (per kg/m2) 0.989 0.983-0.995 .003
Donor female gender 0.943 0.875-1.017 .128
Ischemic time (per h) 1.096 1.065-1.128 <.001
Recipient creatinine (per mg/dL) 1.108 1.082-1.134 <.001
Recipient female gender 0.967 0.897-1.042 .390
Recipient age (per y) 0.999 0.996-1.002 .423
Recipient history of diabetes 1.064 0.966-1.172 .211
White race Ref Ref Ref
Asian race 0.817 0.645-1.034 .093
Black race 1.343 1.231-1.465 <.001
Hispanic race 1.048 0.924-1.188 .466
Sex mismatch 1.059 0.985-1.139 .136
Race mismatch 1.098 1.023-1.178 .010
ECMO as bridge to transplant 2.550 1.854-3.506 <.001
Ventilator as bridge to transplant 2.266 1.954-2.628 <.001
BMI, Body mass index; ECMO, extracorporeal membrane oxygenation.
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Xmanipulate the neurohormonal brain-death milieu to max-
imize donor conversion. We also carried out subgroup
analysis on diabetic donor hearts that were evaluated
with coronary angiography. Recipients of diabetic donors
that had coronary angiography did not have superior
outcomes.
Recipient variables found to be associated with mortality
in this study were creatinine, black race, and requirement of
mechanical ventilation as a bridge to transplantation. These
variables are consistent in what has been established in pre-
vious studies.9-13,22 The requirement of ECMO as a bridge
to transplantation was found to be strongly associated with
death. Other factors associated with mortality in this study
included race mismatch, longer ischemic time, and
increasing donor age. These variables have been shown to
be associated with mortality in prior studies.9-13,23,24
Therewere several limitations to this study, including those
related to its retrospective nature. There are inherent limita-
tions in using a multi-institutional database such as UNOS.
Although we cannot confirm that the data are devoid of cod-
ing errors, any such errors are likely random and unlikely to
create bias. In addition, UNOS does not include all potential
confounders, such as detailed socioeconomic data. There are
some donor characteristics that may confound the results of
the study and could not be evaluated in the UNOS database,
such as severity of nephropathy and presence of myocardial
infarctions. Future studies are needed to determine whether
these variables affect outcomes when using diabetic donors.
Finally, median follow-up for this study was 1189.5 days
and the use of diabetic donors may have long-term effects
that could not be observed in this study period.
In conclusion, this study demonstrates that cardiac
transplantation can be safely performed using carefully446 The Journal of Thoracic and Cardiovascular Surgselected diabetic donors. Such donors can be used for
transplantation with equivalent outcomes, even when the
donor is insulin dependent or has had diabetes for more
than 5 years.References
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